Berlin, Germany

Andreas Theiel

This inventor holds 1 USPTO granted patent. Top assignee: Beutsches Rheuma-Forschungszentrum Berlin (Drfz). Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Theiel. Retrieved from https://idiyas.com/inventor/andreas-theiel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andreas Theiel

Introduction

Andreas Theiel is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of compositions and methods that enhance our understanding of plasma cells.

Latest Patents

Andreas Theiel holds a patent for a composition that comprises an anchor region capable of binding to a plasma cell, along with a binding region associated with the anchor region. This binding region is designed to bind a specific plasma cell antibody. His innovative work in this area has the potential to advance therapeutic strategies in immunology.

Career Highlights

Theiel is affiliated with the Deutsches Rheuma-Forschungszentrum Berlin (drfz), where he has been involved in cutting-edge research. His work has contributed to the understanding of autoimmune diseases and the role of plasma cells in these conditions.

Collaborations

Andreas Theiel collaborates with esteemed colleagues such as Andreas Radbruch and Falk Hiepe. Their combined expertise fosters a productive research environment that drives innovation in their field.

Conclusion

Andreas Theiel's contributions to the field of biomedical research, particularly through his patent and collaborative efforts, highlight his role as an influential inventor. His work continues to pave the way for advancements in understanding plasma cells and their implications in health and disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…